News und Analysen

Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2020 financial results and provide 2021 guidance on Wednesday, February 17^th, before the market

AMN Healthcare’s commitment to developing comprehensive and integrated solutions to the challenges faced by healthcare organizations has resulted in a top-ten ranking among leaders in total

AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, has scheduled a conference call to discuss its fourth quarter and full

Genus plc (LSE: GNS), a global biotechnology leader in animal genetics, today reported continued strong performance across its operations for the six-months period ending December 31, 2020.

The

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with JADE Biomedical (JADE), a provider of end-to-end quality management

In connection with the Company’s participation at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, AMN Healthcare Services Inc. (NYSE: AMN) is providing preliminary unaudited

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at the 39^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12^th, at 10:00

Novocure (NASDAQ: NVCR) today reported operating statistics and preliminary, unaudited net revenues and cash balances for the fourth quarter and full year 2020. Novocure plans to discuss these

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) gab heute die Berufung von Dr. Toralf Haag in den Aufsichtsrat mit sofortiger Wirkung bekannt. Dr. Haag wird gleichzeitig Mitglied des

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that Dr. Toralf Haag has been appointed a member of the Supervisory Board with immediate effect. He will also become a member of

Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2021 second quarter on Tuesday, February 2, 2021, at approximately 6:30 a.m. ET. The company will

ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, and The University of Texas

Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to participate in a presentation and fireside chat at the 39

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it acquired of Distributed Bio, Inc. on December 31, 2020. The acquisition marks the culmination of an exclusive

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia” or the “Company”) today announced that it has entered into a definitive agreement to sell its U.K. operations to Waterland Private Equity

Novocure (NASDAQ: NVCR) will participate virtually in the 39^th Annual J.P. Morgan Healthcare Conference on January 11 through January 14, 2021. William Doyle, Novocure’s Executive Chairman, will

Regulatory News:

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201221005694/en/

Vifor Fresenius Medical Care Renal Pharma (VFMCRP)

Health Resource Services (HRS), a national, provider-owned group purchasing organization (GPO) founded by Virginia Mason Health System, today announced that they will partner with Premier Inc.

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard QIA) gab heute den erfolgreichen Abschluss eines syndizierten revolvierenden Kredits über EUR 400 Mio. bekannt, deren Zinssatz an die Umwelt-

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard QIA) announced today that it has successfully concluded a syndicated revolving credit facility for EUR 400mn with an interest rate linked to the

For its dedication to addressing social issues and supporting people and communities locally, nationally and globally, AMN Healthcare (NYSE: AMN) has been named one of the country’s most

Novocure (NASDAQ:NVCR) gab heute bekannt, dass das Schweizerische Bundesamt für Gesundheit (BAG) Optune in Kombination mit Temozolomid mit Wirkung vom 1. April 2021 in die Mittel- und

Novocure (NASDAQ:NVCR) announced today that the Swiss Federal Office of Public Health (BAG) has added Optune in combination with temozolomide to the List of Remedies and Equipment (MiGeL) for the

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) ("QIAGEN" or the "Company") announces the successful pricing of the following series of transactions:

- The issue of new senior, unsecured